Viking Therapeutics Inc (NASDAQ: VKTX) on Monday, plunged -4.42%% from the previous trading day, before settling in for the closing price of $26.01. Within the past 52 weeks, VKTX’s price has moved between $18.92 and $81.73.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -23.00%. The company achieved an average annual earnings per share of -86.96%. With a float of $108.99 million, this company’s outstanding shares have now reached $112.29 million.
The extent of productivity of a business whose workforce counts for 36 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Viking Therapeutics Inc (VKTX) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Viking Therapeutics Inc is 2.96%, while institutional ownership is 69.46%. The most recent insider transaction that took place on Mar 31 ’25, was worth 29,943. In this transaction Director of this company bought 1,240 shares at a rate of $24.15, taking the stock ownership to the 1,240 shares. Before that another transaction happened on Jan 06 ’25, when Company’s President & CEO sold 194,490 for $42.75, making the entire transaction worth $8,313,601. This insider now owns 2,366,570 shares in total.
Viking Therapeutics Inc (VKTX) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -86.96% per share during the next fiscal year.
Viking Therapeutics Inc (NASDAQ: VKTX) Trading Performance Indicators
Viking Therapeutics Inc (VKTX) is currently performing well based on its current performance indicators. A quick ratio of 44.25 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.15, a number that is poised to hit -0.45 in the next quarter and is forecasted to reach -2.57 in one year’s time.
Technical Analysis of Viking Therapeutics Inc (VKTX)
The latest stats from [Viking Therapeutics Inc, VKTX] show that its last 5-days average volume of 3.47 million was inferior to 4.11 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 13.70%.
During the past 100 days, Viking Therapeutics Inc’s (VKTX) raw stochastic average was set at 34.00%, which indicates a significant increase from 16.64% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.68% in the past 14 days, which was lower than the 76.82% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $26.72, while its 200-day Moving Average is $41.10. Now, the first resistance to watch is $25.95. This is followed by the second major resistance level at $27.03. The third major resistance level sits at $28.11. If the price goes on to break the first support level at $23.79, it is likely to go to the next support level at $22.71. The third support level lies at $21.63 if the price breaches the second support level.
Viking Therapeutics Inc (NASDAQ: VKTX) Key Stats
Market capitalization of the company is 2.79 billion based on 112,310K outstanding shares. Right now, sales total 0 K and income totals -109,960 K. The company made 0 K in profit during its latest quarter, and -45,630 K in sales during its previous quarter.
